Therapix Biosciences Ltd
NASDAQ:TRPX (7/1/2020, 7:22:21 PM)
After market: 0.305 -0.01 (-3.79%)0.317
-0.3 (-48.9%)
Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to the high value and under-served market of mild cognitive impairment are in clinical stage. Therapix Biosciences Ltd is based in Tel Aviv, Israel.
Therapix Biosciences Ltd
4 ARIEL SHARON STREET HASHAHAR TOWER 16TH FLOOR
GIVATAYIM L3 5320047
P: 972-3616-7055
CEO: Gilad Bar-Lev
Struggling cannabinoid-based treatment developer Therapix Biosciences (NASDAQ:TRPX) has replaced its entire six-member board of directors.Itschak Shrem is the new chairman.Nasdaq delisted its ADSs on July 2.
MJCO – MJCO leads the way today as the best performing small cap stock, closing up 72.25%.
VRNA – VRNA leads the way today as the best performing small cap stock, closing up 115.64%.
AHT – AHT leads the way today as the best performing small cap stock, closing up 813.11%.
GENE – GENE leads the way today as the best performing small cap stock, closing up 143.81%.
Here you can normally see the latest stock twits on TRPX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: